SRT-100 is an Optimal Therapy Modality for Non-Melanoma Skin Cancers
0 Views
administrator
07/10/23
Featuring our SharpBeam precision superficial radiotherapy, the SRT-100 is an excellent treatment option for patients with non-Melanoma (NMSC) skin cancers, such as Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Ask your doctor about SRT-100 when you weigh your treatment options!
-
Category
Show more
Facebook Comments
No comments found